
Sign up to save your podcasts
Or


Two big legal cases concerning the fate of FTX founder Sam Bankman-Fried and the CFPB. We’ve got the latest developments on each. Plus, is Microsoft’s new $9B AI tool worth the hype? And the weight-loss drug boom is having major ripple effects on stocks. We’ll look at one buy and one bail as a result of the craze.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC3.9
308308 ratings
Two big legal cases concerning the fate of FTX founder Sam Bankman-Fried and the CFPB. We’ve got the latest developments on each. Plus, is Microsoft’s new $9B AI tool worth the hype? And the weight-loss drug boom is having major ripple effects on stocks. We’ll look at one buy and one bail as a result of the craze.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,100 Listeners

1,366 Listeners

239 Listeners

151 Listeners

977 Listeners

1,173 Listeners

67 Listeners

153 Listeners

34 Listeners

191 Listeners

45 Listeners

1,320 Listeners

591 Listeners

5 Listeners

561 Listeners

21 Listeners

64 Listeners

1,573 Listeners

212 Listeners

409 Listeners

300 Listeners

122 Listeners

175 Listeners

37 Listeners

15 Listeners

33 Listeners

11 Listeners

16 Listeners

0 Listeners